Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Friday, February 3, 2023
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Regulatory Affairs
Regulatory Affairs
Regulatory Affairs
Drug Approval Process in China
admin
-
January 19, 2020
Regulatory Affairs
Approval pathways of Fixed dose combination (FDC) in India
admin
-
January 12, 2020
Regulatory Affairs
Drug Approval Process in India
admin
-
January 4, 2020
Regulatory Affairs
Orphan Drug Designation in US, EU and Japan
admin
-
December 31, 2019
Regulatory Affairs
The Drug approval process in EU:
admin
-
December 29, 2019
Regulatory Affairs
Biologics Approval Pathways in the USA:
admin
-
December 27, 2019
0
Regulatory Affairs
Generic Products Approval Pathways (USA): Paragraph Certification I, II, III, and IV:
admin
-
December 25, 2019
0
Regulatory Affairs
Drug Approval process-FDA
admin
-
December 21, 2019
2
Regulatory Affairs
Medical Device Registration in Japan-Todokede, Ninsho and Shonin Pathways
admin
-
November 23, 2019
0
- Advertisment -
Most Read
Tezspire approved for self-administration in US with a new pre-filled pen
February 3, 2023
FDA Approves First Oral Treatment for Anemia Caused by Chronic Kidney Disease
February 3, 2023
Dupixent approved as first and only targeted medicine indicated for eosinophilic esophagitis
February 3, 2023
Novartis continues to grow with further core margin expansion and achieves important innovation milestones
February 1, 2023